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Research ArticleHematopoietic overexpression of Cyp27a1 reduces
hepatic inflammation independently of 27-hydroxycholesterol
levels in Ldlr/ mice
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University of Bonn, Bonn, GermanyBackground & Aims: Non-alcoholic steatohepatitis (NASH) is occurred even though plasma and liver levels of 27HC did not dif-
characterized by hepatic lipid accumulation and inflammation. fer between both groups. BMDM from Cyp27a1over mice revealed
Currently, the underlying mechanisms, leading to hepatic inflam-
mation, are still unknown. The breakdown of free cholesterol
inside Kupffer cells (KCs) by the mitochondrial enzyme CYP27A1
produces 27-hydroxycholesterol (27HC). We recently demon-
strated that administration of 27HC to hyperlipidemic mice
reduced hepatic inflammation. In line, hematopoietic deletion
of Cyp27a1 resulted in increased hepatic inflammation. In the
current manuscript, the effect of hematopoietic overexpression
of Cyp27a1 on the development of NASH and cholesterol traffick-
ing was investigated. We hypothesized that Cyp27a1 overexpres-
sion in KCs will lead to reduced hepatic inflammation.
Methods: Irradiated Ldlr/ mice were transplanted (tp) with
bone marrow from mice overexpressing Cyp27a1 (Cyp27a1over)
and wild type (Wt) mice and fed either chow or a high-fat,
high-cholesterol (HFC) diet for 3 months. Additionally, gene
expression was assessed in bone marrow-derived macrophages
(BMDM) from Cyp27a1over and Wt mice.
Results: In line with our hypothesis, hepatic inflammation in
HFC-fed Cyp27a1over-tp mice was reduced and KCs were less
foamy compared to Wt-tp mice. Remarkably, these changesJournal of Hepatology 20
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lipoprotein receptor; HFC, high-fat high-cholesterol; Wt, wild type; tp,
transplanted; TG, triglycerides; FFA, free fatty acids; BMDM, bone marrow
derived macrophages; LPS, lipopolysaccharide; NPC, Niemann-Pick type C.reduced inflammatory gene expression and increased expression
of cholesterol transporters compared to Wt BMDM after lipopoly-
saccharide (LPS) stimulation.
Conclusions: Our data suggest that overexpression of Cyp27a1 in
KCs reduces hepatic inflammation independently of 27HC levels
in plasma and liver, further pointing towards KCs as specific tar-
get for improving the therapy of NASH.
 2014 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Introduction
Non-alcoholic fatty liver disease (NAFLD) is considered the hepa-
tic event of the metabolic syndrome and is characterized by the
deposition of fat in the liver (steatosis). NAFLD covers a broad
spectrum of diseases ranging from steatosis to non-alcoholic ste-
atohepatitis (NASH). NASH is distinguished from simple steatosis
by the added presence of inflammation in the liver. Whereas ste-
atosis is generally considered a relatively benign and reversible
condition, inflammation adversely affects the long-term progno-
sis of liver diseases as this enables the development of more
advanced stages of the disease, including fibrosis, cirrhosis or
hepatocellular carcinoma, ultimately requiring liver transplanta-
tion [1]. So far, the intracellular mechanisms that trigger the
inflammatory response are not known. Hence, therapy options
are very poor and lack specificity.
The uptake of dietary cholesterol by Kupffer cells (KCs), the
resident macrophages of the liver, was found to play an impor-
tant role during NASH development [2]. Similar to previously
reported observations during atherosclerosis [3,4], the15 vol. 62 j 430–436
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accumulation of cholesterol leading to a swollen appearance of
macrophages, termed foam cells, was associated with an
increased inflammatory response in the liver [5]. Upon uptake
by macrophages, cholesterol is initially directed to lysosomes
for hydrolyzation and then further transported to the cyto-
plasm. Here, cholesterol can be converted into 27-hydroxycho-
lesterol (27HC) by the action of the mitochondrial enzyme
CYP27A1 as the first step in the alternative pathway of bile
acid formation [6]. Recently, we demonstrated that exogenous
administration of 27HC dramatically reduced hepatic inflam-
mation in hyperlipidemic Ldlr/ mice upon high-fat, high-cho-
lesterol (HFC) feeding [7]. In line with this observation,
hematopoietic deletion of Cyp27a1 resulted in increased hepatic
inflammation [7].
We hypothesized that hematopoietic overexpression of
Cyp27a1 will lead to reduced hepatic inflammation. In order to
investigate the effect of overexpression of Cyp27a1 in KCs on
hepatic inflammation, bone marrow chimeras were generated
by injecting bone marrow cells from mice overexpressing
Cyp27a1 (Cyp27a1over) into lethally irradiated Ldlr/ hyperlipi-
demic host mice. In the current study we show that overexpres-
sion of Cyp27a1 in KCs reduces hepatic inflammation,
independently of hepatic and plasma 27HC levels.Materials and methods
Bone marrow-derived macrophages
Bone marrow-derived macrophages were isolated from the tibiae and femurs of
C57BL/6 or Cyp27a1over mice (kindly provided by E. Leitersdorf [8]). Cells were
cultured in RPMI-1640 (GIBCO Invitrogen, Breda, the Netherlands) with 10%
heat-inactivated foetal calf serum (Bodinco B.V. Alkmaar, the Netherlands), pen-
icillin (100 U/ml), streptomycin (100 lg/ml) and L-glutamine 2 mM (all GIBCO
Invitrogen, Breda, the Netherlands), supplemented with 20% L929-conditioned
medium (LCM) for 8–9 days to generate bone marrow-derived macrophages.
After attachment, macrophages were seeded at 350,000 cells per well in 24-well
plates and incubated for 24 h with medium (control), cyclodextrin (carrier con-
trol) or 27HC (0.25 lM; 1 lM). Then cells were washed and stimulated with
LPS (100 ng/ml) for 4 h. Finally, cells were lysed for mRNA expression analysis.
For protein expression analysis and electron microscopy analysis, cells were
seeded at 2,000,000 cells per well in 6-well plates and incubated under the same
conditions.Mice, diet, and bone marrow transplantation
Mice were housed under standard conditions and given free access to food and
water. Experiments were performed according to the Dutch regulations and
approved by the Committee for Animal Welfare of the Maastricht University.
Female 12-week-old Ldlr/ mice were lethally irradiated and transplanted with
Wt or Cyp27a1over bone marrow as previously described [9]. After a recovery per-
iod of 9 weeks, the mice were given either chow or HFC diet for 3 months (chow:
n = 5; HFC: n = 10). The HFC diet contained 21% milk butter, 0.2% cholesterol, 46%
carbohydrates, and 17% casein. Collection of blood and tissue specimens, bio-
chemical determination of lipids in plasma and liver, liver histology, electron
microscopy, RNA isolation, cDNA synthesis, qPCR and oxysterol levels were deter-
mined as described previously [7,10].Statistical analysis
Data were analysed using the Graphpad Prism 4.0.3 software. Groups were com-
pared using the unpaired t test for comparing two groups or one-way ANOVA for
comparing multiple groups. Data were expressed as the mean and standard error
of the mean and were considered significantly different at ⁄p <0.05; ⁄⁄p <0.01; or
⁄⁄⁄p <0.001.Journal of Hepatology 201Results
Cyp27a1over-tp mice have less hepatic inflammation compared to
Wt-tp mice
The effect of hematopoietic overexpression of Cyp27a1 in diet-
induced NASH was investigated by transplanting bone marrow
from wild type (Wt) and Cyp27a1 overexpressing (Cyp27a1over)
mice into Ldlr/ mice. After a recovery period of 9 weeks, mice
received chow or HFC diet for 3 months. Body weight did not dif-
fer significantly between the groups (data not shown). To inves-
tigate the effect of hematopoietic overexpression of Cyp27a1 on
hepatic inflammation, liver sections were stained with antibodies
against several inflammatory markers including macrophages
and neutrophils. Lower numbers of infiltrating macrophages
(p = 0.0206) and neutrophils (p = 0.0146) were observed in the
livers of Cyp27a1over-tp mice compared to Wt-tp mice after HFC
(Fig. 1A), as further illustrated by representative pictures from
Mac-1 staining for infiltrating macrophages and neutrophils
(Fig. 1B). These findings were confirmed by reduced hepatic gene
expression of the monocyte chemo-attractant protein 1 (Mcp1)
(p = 0.0083), chemokine (C-X-C motif) ligand 1 (Cxcl1)
(p = 0.046), and Cxcl2 (p = 0.039) in Cyp27a1over-tp mice com-
pared to Wt-tp mice upon HFC (Fig. 1C), whereas gene expression
for tumor necrosis factor-alpha (Tnfa) showed the same trend,
although it did not reach significance (p = 0.07). Taken together,
these data indicate that hematopoietic overexpression of
Cyp27a1 reduces hepatic inflammation.
To investigate the effect of overexpression of Cyp27a1 in
hematopoietic cells on apoptosis, hepatic expression of genes
important during apoptosis was determined. Compared to ani-
mals on chow, expression of the apoptotic genes Bfl1 and Traf1
was increased after 3 months of HFC diet. However, no difference
was observed between Wt-tp and Cyp27a1over-tp mice (Supple-
mentary Fig. 1A). In line with these findings, no difference
between Wt-tp and Cyp27a1over-tp mice was found in hepatic
expression of catalase (Cat), SOD2, Hmox, and Cyp2E1, markers
for oxidative stress (Supplementary Fig. 1B). To further character-
ize these two genotypes, markers for liver damage and fibrosis
were analysed. As expected, plasma alanine transaminase (ALT)
levels were increased in mice after 3 months of HFC feeding. Sim-
ilar ALT levels were observed in Wt-tp and Cyp27a1over-tp mice.
Additionally, hepatic gene expression of Tgfb, a marker for fibrosis
development, was unchanged between Wt-tp and Cyp27a1over-tp
mice upon HFC diet (Supplementary Fig. 1C). To evaluate macro-
phage polarization in the livers of both transplanted groups,
hepatic gene expression analysis of IL12, an M1 macrophage mar-
ker, was measured and revealed no difference between the two
groups. Likewise, no difference was observed in the expression
of the M2 macrophage markers arginase-1 (Arg1) and IL10 after
3 months of HFC feeding (Supplementary Fig. 1D). Taken
together, these data indicate that hematopoietic overexpression
of Cyp27a1 reduces hepatic inflammation independent of the
level of apoptosis, oxidative stress, liver damage or macrophage
subset polarization.
Levels of 27-hydroxycholesterol in liver and plasma are not affected
by hematopoietic Cyp27a1 overexpression
After three months of HFC diet, no difference was found between




































































































Fig. 1. Parameters of hepatic inflammation in Wt-tp and Cyp27a1over-tp mice.
(A) Liver sections were stained for infiltrating macrophages and neutrophils
(Mac-1), neutrophils (NIMP) and positive cells were counted. (B) Representative
pictures of Mac-1 staining (200magnification) after 3 months of HFC diet in Wt-
tp and Cyp27a1over-tp mice. (C) Gene expression analysis of monocyte chemoat-
tractant protein 1 (Mcp1), tumor necrosis factor alpha (Tnfa), chemokine (C-X-C
motif) ligand 1 (Cxcl1) and Cxcl2. Gene expression data were set relative to Wt-tp
mice on chow diet. ⁄Indicates p <0.05 and ⁄⁄p <0.01. (This figure appears in colour
on the web.)
Research Articletriglycerides (TGs), cholesterol and free fatty acids (FFAs) (Sup-
plementary Fig. 2A). In addition, while plasma lipid levels were
increased in mice receiving HFC for 3 months, hematopoietic
overexpression of Cyp27a1 did not affect plasma lipid levels.
Total cholesterol, TG and FFA levels in plasma were not different
in Cyp27a1over-tp mice compared to their controls, both in mice
on chow as well as on HFC (Supplementary Fig. 2B). Altogether,
hematopoietic overexpression of Cyp27a1 does not affect plasma
and liver lipid levels.
In order to study the effect of Cyp27a1 overexpression on 27-
hydroxycholesterol levels in hematopoietic cells, 27-hydroxycho-
lesterol in liver and plasma was measured in Wt-tp and
Cyp27a1over-tp mice. Surprisingly, no difference in the levels of432 Journal of Hepatology 20127-hydroxycholesterol in liver and plasma between both trans-
planted groups were observed (Fig. 2A).
Additionally, in order to investigate whether hematopoietic
overexpression of Cyp27a1 is related to changes in the level of
other oxysterols, levels of 7a- and 24-hydroxycholesterol in liver
and plasma were measured. There were no differences observed
in 7a- and 24-hydroxycholesterol levels in the livers and plasma
of Cyp27a1over-tp mice compared to Wt-tp mice (Fig. 2B). Taken
together, these data indicate that the observed anti-inflammatory
effect is not related to changes in oxysterol levels in liver and
plasma.
To further investigate the similarity in systemic and hepatic
levels of 27HC between the two groups, gene expression analysis
of hepatic Cyp7b1, Cyp7a1, and Cyp27a1 was performed. No dif-
ference in the expression of Cyp7b1 between Wt-tp and
Cyp27a1over-tp mice was found, suggesting that degradation of
27HC is not different between the groups (Fig. 2C). Hepatic gene
expression levels of Cyp7a1 were increased in Cyp27a1over-tp
mice compared to control mice (Fig. 2C), suggesting that more
cholesterol is broken down in the classic pathway and therefore
production of hepatic and systemic 27HC is not significantly
increased in Cyp27a1over-tp mice. Furthermore, gene expression
of Cyp27a1 in total liver was not different between Wt-tp and
Cyp27a1over-tp mice (Fig. 2C). Altogether, these data suggest that
the increased systemic and hepatic production of 27HC is pre-
vented by upregulation of the classical pathway.
In order to further evaluate possible protective mechanisms of
Cyp27a1 overexpression, the amount of free cholesterol and cho-
lesteryl esters in the liver were measured. Results of these mea-
surements show that the amount of free cholesterol in livers of
Cyp27a1over-tp mice is not different from the amount in Wt-tp
mice (Supplementary Fig. 3A). Interestingly, hepatic levels of cho-
lesteryl esters were dramatically reduced in Cyp27a1over-tp mice
compared to the levels in Wt-tp mice (Supplementary Fig. 3A). In
order to investigate any difference in the production of choleste-
ryl esters, gene expression analysis of ACAT2 was performed.
Although there was a trend towards a reduction, compared to
Wt-tp mice upon HFC, hepatic ACAT2 expression was unchanged
in mice overexpressing Cyp27a1 in hematopoietic cells (Supple-
mentary Fig. 3B). Taken together, these data indicate that
Cyp27a1 overexpression can protect from hepatic inflammation
by reduced accumulation of cholesteryl esters in the liver, with-
out affecting cholesteryl production by ACAT2.Less foamy Kupffer cells in Cyp27a1over-tp mice compared to Wt-tp
mice
To analyse the effect of Cyp27a1 overexpression on the foamy
appearance of KCs, a CD68 staining (for KC) was performed and
revealed a clear difference between Cyp27a1over-tp mice and
Wt-tp mice upon HFC diet. In Cyp27a1over-tp mice, KCs are less
swollen and foamy compared to KCs in Wt-tp animals (Supple-
mentary Fig. 4A). These data are in line with reduced gene
expression of Cd68 in the livers of Cyp27a1over-tp mice compared
to Wt-tp mice after 3 months of HFC feeding (Supplementary
Fig. 4B).
To investigate whether the difference in foamy appearance of
KCs is related to changes in cholesterol uptake or cholesterol
efflux, gene expression analysis was performed. For cholesterol
uptake, hepatic expression of Cd36, scavenger receptor a (SR-A),








































































































































































Wt -tp Cyp27a1over -tp
Fig. 2. Liver and plasma oxysterol levels in Wt-tp and Cyp27a1over-tp mice. (A) Liver and plasma 27-hydroxycholesterol levels after chow and HFC diet. (B) Liver and
plasma 7a-hydroxycholesterol and 24-hydroxycholesterol levels after chow and HFC diet. (C) Gene expression analysis of hepatic Cyp7b1, Cyp7a1, and Cyp27a1 in Wt-tp and
Cyp27a1over-tp mice. Gene expression data were set relative to Wt-tp mice on chow diet. ⁄Indicates p <0.05.
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Fig. 3. Gene expression in bone marrow-derived macrophages from Wt and
Cyp27a1over mice after LPS stimulation. Gene expression analysis of the
inflammatory marker tumor necrosis factor alpha (Tnfa) (A), scavenger receptors
Cd36 and SR-A (B), liver X receptor alpha (LXRa) and ATP-binding cassette
transporter A1 (Abca1) and G1 (Abcg1) (C) in BMDM from Wt and Cyp27a1over
mice after 4 h LPS stimulation. Data were set relative to BMDM from Wt mice
incubated with medium. ⁄Indicates p <0.05 and ⁄⁄p <0.01.
JOURNAL OF HEPATOLOGYSR-B1 did not differ between Wt-tp and Cyp27over-tp mice upon
HFC (Supplementary Fig. 4C). Next to that, no difference in hepa-
tic expression of two well-known cholesterol efflux transporters,
Abca1 and Abcg1, was observed between Wt-tp and Cyp27over-tp
mice (Supplementary Fig. 4D). Together, these data indicate that
changes in the foamy appearance of KCs are not related to choles-
terol uptake and reverse cholesterol transport in total liver.
Bone marrow-derived macrophages (BMDM) from Cyp27a1over mice
have increased intracellular cholesterol trafficking
In order to investigate the mechanism by which Cyp27a1 reduces
inflammation, bone marrow cells were isolated from Wt and
Cyp27a1over mice and cultured to macrophages. After stimulation
with lipopolysaccharide (LPS) for 4 h, the expression of Tnfa was
significantly lower in BMDM from Cyp27a1over mice compared to
those from Wt mice, confirming our in vivo findings that Cyp27a1
overexpression in macrophages results in a reduced inflamma-
tory response (Fig. 3A).
To study the specific effect of Cyp27a1 overexpression on cho-
lesterol uptake by macrophages, the expression of Cd36 and SR-A
was analysed with and without LPS stimulation. No difference
was observed between BMDM from Wt and from Cyp27a1over
mice (Fig. 3B). On the other hand, expression of liver X receptor
alpha (LXRa) (p = 0.025), Abca1 (p = 0.0094), and Abcg1
(p = 0.0462), genes involved in cholesterol efflux, was increased
in BMDM from Cyp27a1over mice compared to Wt BMDM after
LPS stimulation (Fig. 3C). These data indicate that Cyp27a1Journal of Hepatology 201overexpression in macrophages leads to an increase of choles-
terol efflux transport during an inflammatory response.
To further examine the effect of Cyp27a1 overexpression on
intracellular cholesterol trafficking in macrophages, gene5 vol. 62 j 430–436 433
NPC1








































































































Fig. 4. Gene expression and protein levels in bone marrow-derived macrophages from Wt and Cyp27a1over mice of genes important in intracellular cholesterol
trafficking. (A) Niemann-Pick C1 (Npc1) and Npc2 gene expression in BMDM from Wt and Cyp27a1over mice after 4 h LPS stimulation. (B) Representative pictures of 5
independent Western blot measurements. Western blot analysis of Npc1 and Npc2 proteins in BMDM from Wt mice after 4 h of LPS stimulation and incubation with
cyclodextrin (carrier control) and 27-hydroxycholesterol. Beta-actin was used as loading control. (C) Representative electron microscopy pictures (acid phosphatase
staining) of Wt BMDM incubated with medium, cyclodextrin, or 27HC. Pictures of approximately 25 BMDM were scored for lysosomal cholesterol accumulation. Data were
set relative to BMDM from Wt mice incubated with medium. ⁄Indicates p <0.05; ⁄⁄p <0.01; ⁄⁄⁄p <0.001.
Research Articleexpression analysis for genes important for lysosomal cholesterol
transport (Npc1 and Npc2) was assessed. Whereas Npc1 expres-
sion was not affected by LPS stimulation, the expression of
Npc2 increased dramatically after stimulation with LPS in both
BMDM from Wt and Cyp27a1over mice (Fig. 4A). Notably, macro-
phages overexpressing Cyp27a1 showed increased expression of
Npc2 compared to Wt BMDM after LPS stimulation (Fig. 4A).
Additionally, in order to study specifically the effect of 27HC on
macrophages, protein levels of Npc1 and Npc2 were determined
in BMDM from Wt mice that were incubated with 27HC and
cyclodextrin (carrier control). Interestingly, 27HC incubation led
to a significant induction of NPC1 and NPC2 protein levels com-
pared to control condition (Fig. 4B). This increase was accompa-
nied by a reduction in lysosomal cholesterol accumulation in
BMDM, incubated with 27HC as shown in the electron micros-
copy pictures (Fig. 4C). While adding cyclodextrin to macro-
phages resulted in a trend towards a reduction in lysosomal
cholesterol accumulation, adding 27HC was able to dramatically
reduce lysosomal cholesterol accumulation in comparison to con-
trol and compared to the cyclodextrin condition. Thus, 27HC is
more effective in reducing lysosomal cholesterol accumulation
than its vehicle cyclodextrin. Taken together, these data suggest
that Cyp27a1 and 27HC are able to modulate intracellular choles-
terol trafficking in macrophages via NPC proteins.Discussion
Our results indicate that Cyp27a1 overexpression in hema-
topoietic cells reduces diet-induced hepatic inflammation.434 Journal of Hepatology 201Remarkably, the reduction in hepatic inflammation was indepen-
dent of plasma and liver levels of 27-hydroxycholesterol and
other oxysterols. Mechanistically, our data suggest that Cyp27a1
can reduce hepatic inflammation via modulation of intracellular
cholesterol trafficking in macrophages. Furthermore, our data
provide further evidence to the importance of KCs in triggering
hepatic inflammation.
CYP27A1 is able to reduce hepatic inflammation independent of
circulating 27HC levels
Currently, most data are highly controversial regarding the activ-
ities of oxysterols. Although some in vitro studies have demon-
strated that oxysterols have some cytotoxic, oxidative, and/or
inflammatory effects [11], the most abundant oxysterol, being
27HC, is considered as a potential candidate for the reduction
of inflammation during NASH [7]. Daily injection of 27HC was
found to result in reduced hepatic inflammation in a dietary
model for NASH. As expected, in addition to the reduced inflam-
matory response upon 27HC administration, increased levels of
27HC in liver and plasma were detected [7]. Importantly, 27HC
was found to be a selective oestrogen receptor modulator that
can serve as a competitive antagonist for the oestrogen receptor
[12,13]. As such, circulating levels of 27HC levels may directly
antagonize the functions of oestrogen receptors in vascular endo-
thelial and smooth muscle cells, thereby leading to a loss of the
cardioprotective effect of oestrogen [14]. Furthermore, increased
levels of 27HC, which occur during hypercholesterolemia, have
recently been shown to be involved in different pathologies. In
a mouse model for breast cancer, it was shown that 27HC5 vol. 62 j 430–436
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increases oestrogen receptor-dependent growth and LXR-depen-
dent metastasis [15]. Mice that demonstrated increased circulat-
ing levels of 27HC showed increased metastasis of breast cancer
cells to the lung. Besides involvement in breast cancer, it was
shown that increased concentrations of 27HC led to decreased
bone mineral density that was associated with decreased bone
formation and increased bone resorption [12]. Our current data
indicate that increased Cyp27a1 expression, specifically in hema-
topoietic cells, does not alter circulating 27HC levels while
inflammation is reduced. Our data suggest that the increased sys-
temic and hepatic production of 27HC is prevented by upregula-
tion of the classical pathway. Another explanation for the similar
levels of systemic and hepatic levels of 27HC between the groups
is the fact that parenchymal cells compromise about 80% of all
liver cells. In our study, gene expression of Cyp27a1 in total liver
was not different between Wt-tp and Cyp27a1over-tp mice. There-
fore, hematopoietic overexpression of Cyp27a1 is not likely to be
reflected in increased 27HC levels in plasma and liver. Therefore,
our data further point towards therapy options wherein CYP27A1
is specifically targeted in KCs.
CYP27A1 modulates intracellular cholesterol trafficking via NPC
proteins
The observation that hematopoietic Cyp27a1 overexpression
leads to a reduced foamy appearance of KCs while neither choles-
terol uptake, nor reverse cholesterol transport was modulated in
total liver suggests that overexpression of Cyp27a1 only affected
intracellular cholesterol trafficking inside KCs. Our current obser-
vations are in line with our previous findings that indicated that
the agonistic effect of 27HC on the liver X receptor (LXR) in KCs is
not dominant in all liver cells, but is restricted to KCs [7]. In line
with our data it was shown that introducing the expression of
Cyp27a1 in vitro, by transfecting cells, stimulated cholesterol
efflux compared to untransfected control cells [16]. Additionally,
pre-incubation of non-transfected cells with 27HC led to
increased cholesterol efflux by 24–60% [16]. Others have reported
that this process may occur via LXR-stimulation, as it is known
that 27HC and possibly another product of CYP27A1, cholestenoic
acid, may be ligands of LXR, regulating a number of genes
involved in lipid metabolism including Abca1 [17]. Interestingly,
hepatic levels of cholesteryl esters were dramatically reduced
in Cyp27a1over-tp mice compared to the levels in Wt-tp mice in
our study. In line with our findings, it was demonstrated that
reduced cholesteryl esters, by transgenic overexpression of the
cholesteryl ester hydrolase (CEH) in macrophages, polarizes
Kupffer cells to a more anti-inflammatory phenotype that atten-
uates hepatic lipid synthesis and accumulation [18]. Further-
more, macrophage CEH overexpression was found to reduce
atherosclerosis and necrosis in Ldlr/ mice, while free choles-
terol levels were unchanged [19,20]. In addition, accumulation
of cholesteryl esters during cholesteryl ester storage disease is
known to be associated with increased inflammation in different
tissues and accelerated atherosclerosis [21].
Although 27HC was previously shown to be able to influence
intracellular cholesterol transport from lysosomes to the cyto-
plasm [7,22], the mechanism involved is not yet known. The
two main proteins that are involved in cholesterol transport from
lysosomes to the cytoplasm are Niemann-Pick C1 (NPC1) and
NPC2. While NPC1 is a multiple membrane spanning domain pro-Journal of Hepatology 201tein containing a sterol sensing domain, NPC2 is a small intralys-
osomal protein that has been characterized biochemically as a
cholesterol-binding and transport protein [23]. A defect in either
of these proteins results in Niemann-Pick disease type C, charac-
terized by lysosomal cholesterol accumulation and inflammation
in different tissues including the liver. Interestingly, it was shown
that NPC1 and NPC2-deficient cells have a severely reduced pro-
duction of 27HC, and that upon incubation with 27HC the lyso-
somal cholesterol pool in NPC1/ fibroblasts is dramatically
reduced [22]. In line with these data, we observed for the first
time that Cyp27a1 overexpression is able to increase NPC1 and
NPC2 gene expression and protein levels. After binding, NPC2 is
able to deliver cholesterol intracellular via interaction with the
phospholipid bilayer, thereby reaching a putative transmem-
brane transporter via lateral diffusion in the plane of the mem-
brane, or it could flip across the limiting lysosomal membrane
and become accessible for transportation to the plasma mem-
brane [24]. Alternatively, NPC2 is able to directly interact with
NPC1 or other lysosomal membrane proteins, resulting in the
removal of cholesterol from the lysosome [25]. In this way,
NPC1 and NPC2 function as a tag team duo to mobilize choles-
terol [24,26]. Our data suggest that 27HC can stimulate NPC-
mediated cholesterol binding and transportation to the lysosomal
membrane, where it can be released out of lysosomes. Taken
together, our studies provide a new mechanism by which
Cyp27a1 can modulate intracellular cholesterol trafficking in
macrophages, thereby leading to reduced inflammation.
While both intracellular cholesterol trafficking and cholesterol
efflux can modulate inflammation, the increased NPC expression
observed in Cyp27a1over-tp mice is probably the main reason for
the reduced inflammatory response observed in Cyp27a1over-tp
mice. Increased cholesterol efflux was shown to modulate the
immune response and inflammation through direct and indirect
anti-inflammatory mechanisms [17]. However, it was reported
previously that the total amount of cholesterol in cells is not cor-
related directly with inflammation, but rather the amount of cho-
lesterol trapped inside lysosomes [2], suggesting an important
role for NPC proteins in the inflammatory response. Moreover,
studies in both arteries and in cell culture have shown that accu-
mulated cholesterol in lysosomes cannot be decreased simply by
inhibiting further uptake of lipoproteins or by increasing efflux of
extra-lysosomal cholesterol stores [27–29]. On the other hand,
increasing the expression of the NPC1 protein led to increased
cholesterol efflux and the inhibition of atherosclerosis [30]. Thus,
increased cholesterol efflux can also be a consequence of
increased NPC expression. To conclude, while both pathways
contributes to the reduced inflammatory response observed in
the Cyp27a1over-tp mice, stimulating cholesterol transport out of
lysosomes seems to play a more dominant role.
In summary, we have shown for the first time that overex-
pression of Cyp27a1, specifically in macrophages, is able to
reduce hepatic inflammation. Mechanistically, our data suggest
that Cyp27a1 can modulate intracellular cholesterol trafficking
by increasing NPC1 and NPC2 expression. This effect is likely
regulated via increased intracellular levels of 27HC, while cir-
culating levels of 27HC are unchanged between the trans-
planted groups. Taken together, our data point towards the
potential of targeted therapy options during the development
of NASH and other inflammatory-related disorders, such as
atherosclerosis.5 vol. 62 j 430–436 435
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